Skip to content

Eriodictyol targets the ubiquitination/phosphorylation of apoptosis signal-regulating kinase 1 and alleviates pressure-overload induced myocardial fibrosis in mice.

Aug 2026 · British Journal of Pharmacology · 0 citations · 43 references
Medicine

TL;DR

ERIO is a safe, effective natural flavonoid with promising preclinical efficacy, suggesting its potential clinical translation for myocardial fibrosis and offering new therapeutic targets to prevent heart failure progression.

Abstract

Background

AND

Purpose

Myocardial fibrosis, a critical pathogenic driver of cardiovascular events, is primarily characterized by extracellular matrix deposition and cardiac fibroblast proliferation and activation. Eriodictyol (ERIO) is an extractable natural compound widely found in fruits and vegetables, possessing positive antioxidant and anti-inflammatory benefits. This study primarily explores the role and molecular mechanism of ERIO in pressure overload-induced myocardial fibrosis. EXPERIMENTAL APPROACH We established an in vivo cardiac remodelling model using transverse aortic constriction (TAC) surgery and an in vitro myocardial fibrosis model induced by transforming growth factor β (TGF-β). For mechanistic exploration, we administered adeno-associated virus (AAV) carrying cardiac fibroblast-specific apoptosis signal-regulating kinase 1 (ASK1) overexpression via tail vein injection, generated a cardiac fibroblast-specific ASK1 knockout mouse model, and established an in vitro neonatal rat cardiac fibroblast (NRCF) model with co-intervention of the selective ASK1 inhibitor GS-4977. KEY

Results

ERIO significantly improved pressure overload-induced cardiac dysfunction and myocardial fibrosis. In addition, ERIO inhibited oxidative stress and inflammatory responses and improved mitochondrial function. Specifically, our mechanistic study revealed that ERIO binds to the K398 site of ASK1, regulating its ubiquitination and phosphorylation activation, down-regulating its downstream JNK/P38 signalling axis and inhibiting the proliferation and activation of cardiac fibroblasts.

Conclusions

AND IMPLICATIONS ERIO is a safe, effective natural flavonoid with promising preclinical efficacy, suggesting its potential clinical translation for myocardial fibrosis and offering new therapeutic targets to prevent heart failure progression.

View source

Similar papers

Oct 2026

The deubiquitinase OTUD6B regulates cardiac hypertrophy by stabilizing TNF receptor associated factor 2.

AIMS Pathological cardiac hypertrophy serves as the primary pathological driver of heart failure, significantly impacting patient prognosis. Deubiquitinating enzymes, which play pivotal roles in protein homeostasis, are emerging as key regulators in cardiac hypertrophy and dysfunction. This study sought to elucidate th...

Wei Zhao, Qi-Lin Li, Huan Zhao et al. · 0 citations
Open access Sep 2026

Therapeutic Potential of the Deubiquitinase BRCC3 in Attenuating Ischemic Myocardial Injury and Ventricular Remodeling

It is demonstrated that BRCC3 protects against ischemic injury and pathological remodeling by deubiquitinating Smad3 at K333 to antagonize TGF-β1/Smad3 signaling, identifying BRCC3 as a potential therapeutic target for preventing post-AMI heart failure.

De-Shan Yao, Si-Chuan Wang, Ru-Jun Li et al. · 0 citations
Aug 2026

The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension.

OBJECTIVE Pulmonary hypertension (PH) involves endothelial-to-mesenchymal transition (EndMT) in vascular remodeling. Rosiglitazone (RSG), a peroxisome proliferator-activated receptor gamma agonist, alleviates PH, but its direct effect on EndMT is unclear. The study explores RSG's role and mechanism in inhibiting EndMT....

Ao-Xue Yuan, Yaqian Bai, Yuanhang Jiang et al. · 0 citations
Open access Sep 2026

FGFR1/KLB-MFG-E8 Maintains Microvascular Integrity and Adaptive Cardiac Remodeling

Background: Endothelial defects in the heart are a contributor to cardiac pathological remodeling and dysfunction, which can be influenced by cardiomyocytes (CMs). Here, we explore cardioprotective crosstalk between CMs and endothelial cells (ECs) under diabetic conditions. Methods: Type 2 diabetes mellitus (T2DM) was...

S. Gare, N. H. Alatawi, Xin-Yi Chen et al. · 0 citations
Open access Sep 2026

Gentiopicroside Regulates EGFR and Induces Its Lysosomal Degradation to Attenuate Heart Failure.

Cardiac hypertrophy is a major pathological response to cardiovascular stress and a critical contributor to heart failure (HF). Gentiopicroside (GPS), a naturally occurring iridoid glycoside derived from Gentiana scabra, exhibits anti-inflammatory, antioxidant, and anti-fibrotic properties. However, its role and molecu...

Ming-Zhen Cao, Da Ke, Jian Ni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.